NEW YORK--(BUSINESS WIRE)--Nov 16, 2024--
Dante Genomics, a global leader in genomics and personalized medicine, announced today that it will begin integrating Generative AI features into its first product, the Dante Labs Whole Genome platform. This milestone represents a significant step forward in the company’s mission to make genomic data more actionable and accessible for both researchers and individuals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241115455133/en/
"Generative AI cannot be a black box in genomics and diagnostics," said Andrea Riposati, CEO and co-founder of Dante Genomics. "We are taking the approach of autopilots on airplanes, supporting the human pilot to make important more informed decisions."
The integration of Generative AI is the result of months of rigorous development and testing, ensuring that the technology meets the highest standards of accuracy and reliability in genomic interpretation. The initiative aligns with Dante Genomics' broader vision to provide scalable, user-friendly tools for decoding the complexities of the human genome.
A Generative AI Revolution in Genomics
The new Generative AI features are designed to transform the way genomic data is interpreted:
Commitment to Quality and Impact
This announcement builds on Dante Genomics' history of excellence in genomics. The company remains steadfast in its commitment to quality, having achieved multiple certifications for its technologies and adhering to stringent international standards. The Generative AI integration reflects the company’s continued investment in technologies that make a tangible difference in people’s lives.
The updated Dante Labs Whole Genome platform with Generative AI features will be available globally starting Q1 2025, with early access offered to select customers.
Dante Labs AI (Graphic: Business Wire)
LAS VEGAS (AP) — Orlando guard Jalen Suggs left the arena aided by a wheelchair on Saturday night after an NBA Cup semifinal loss to New York, and the already short-handed Magic will now wait to learn the severity of his left hip injury.
Suggs was shaken up when he was fouled and landed on the hip late in the second quarter but played on until the fourth quarter. He eventually left the game and headed to the locker room for the final minutes of Orlando's 132-120 loss to the New York Knicks.
Suggs finished with 26 points — 25 coming in the first half. The wheelchair usage was a precaution, largely just to keep Suggs from taking an extended walk to the bus that would carry the Magic back to their hotel. But the hip is clearly cause for some concern.
“We’re going to look at it when we get back,” Magic coach Jamahl Mosley said. “At the end of the day, he’s a warrior for being out there and dealing what he’s dealing with. I think we’ll evaluate him when we get back home and see where he is with it.”
The good news for Orlando — which is flying home on Sunday — is that it doesn't play again until Thursday when it opens a four-game trip in Denver. The bad news is that the Magic are already without brothers Franz Wagner and Moritz Wagner; Franz has a high ankle sprain, Moritz is still recovering from an ACL tear suffered last season.
To lose Suggs for any amount of time would be another blow for a team that's had no shortage of injury issues over the last couple seasons.
“He’s been battling through some pain the last few games,” Magic forward Paolo Banchero said. “He’s just been giving it his all for the team and kind of playing through it. So you hope it’s not too bad, whatever injury it is. You don’t want to lose him. But he gave us a great effort in that first half.”
Suggs was limited to 35 games last season with injuries.
“We know who he is and what he’s about,” Orlando's Desmond Bane said. “He wants to win more than anything. He laid it all on the line for us.”
AP NBA: https://apnews.com/NBA
Orlando Magic guard Jalen Suggs (4) deflects a pass by Miami Heat guard Davion Mitchell, left, during the second half of an NBA Cup basketball game, Tuesday, Dec. 9, 2025, in Orlando, Fla. (AP Photo/Phelan M. Ebenhack)
